Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Anthony S. GibneySEE REMARKS | Aura BiosciencesAURA | Open-market sale | 06/16 | 06/16 | 12,824 sh | $6.42 | $82,330.08 | −4.6% |
Matrix Capital Management Company10% Owner | Aura BiosciencesAURA | Open-market sale | 05/07 | 05/11 | 6,922,870 sh | $5.64 | $39,044,986.8 | −100.0% |
David E. Goel10% Owner | Aura BiosciencesAURA | Open-market sale | 05/07 | 05/11 | 6,922,870 sh | $5.64 | $39,044,986.8 | −100.0% |
Conor KilroySEE REMARKS | Aura BiosciencesAURA | Open-market sale | 04/16 | 04/16 | 11,738 sh | $7.02 | $82,400.76 | −5.1% |
Conor KilroySEE REMARKS | Aura BiosciencesAURA | Open-market sale | 02/17 | 02/17 | 12,079 sh | $5.05 | $60,998.95 | −6.7% |
Plavsic MarkCTO | Aura BiosciencesAURA | Open-market sale | 02/17 | 02/17 | 15,890 sh | $5.05 | $80,244.5 | −8.1% |
de los Pinos ElisabetSEE REMARKS | Aura BiosciencesAURA | Open-market sale | 02/17 | 02/17 | 47,648 sh | $5.06 | $241,098.88 | −10.4% |
Hopkins Janet JillChief Medical Officer | Aura BiosciencesAURA | Open-market sale | 02/17 | 02/17 | 20,401 sh | $5.06 | $103,229.06 | −8.1% |
Elazzouzi AmySVP, Finance | Aura BiosciencesAURA | Open-market sale | 02/17 | 02/17 | 8,549 sh | $5.06 | $43,257.94 | −10.2% |
de los Pinos ElisabetSEE REMARKS | Aura BiosciencesAURA | Open-market sale | 01/20 | 01/20 | 16,928 sh | $4.86 | $82,270.08 | −3.6% |
Elazzouzi AmySVP, Finance | Aura BiosciencesAURA | Open-market sale | 01/20 | 01/20 | 1,581 sh | $4.86 | $7,683.66 | −1.8% |
Hopkins Janet JillChief Medical Officer | Aura BiosciencesAURA | Open-market sale | 25/11/17 | 25/11/17 | 17,109 sh | $5.42 | $92,730.78 | −6.3% |
de los Pinos ElisabetSEE REMARKS | Aura BiosciencesAURA | Open-market sale | 25/10/29 | 25/10/29 | 9,049 sh | $6.35 | $57,461.15 | −1.9% |
Elazzouzi AmySVP, Finance | Aura BiosciencesAURA | Open-market sale | 25/10/29 | 25/10/29 | 896 sh | $6.35 | $5,689.6 | −1.0% |
Plavsic MarkCTO | Aura BiosciencesAURA | Open-market sale | 25/10/16 | 25/10/16 | 12,169 sh | $6.35 | $77,273.15 | −5.8% |
Elazzouzi AmySVP, Finance | Aura BiosciencesAURA | Open-market sale | 25/08/18 | 25/08/18 | 7,722 sh | $6.70 | $51,737.4 | −8.2% |
Anthony S. GibneySEE REMARKS | Aura BiosciencesAURA | Open-market buy | 25/05/16 | 25/05/20 | 50,000 sh | $4.90 | $245,000 | +591.6% |
Anthony S. GibneySEE REMARKS | Aura BiosciencesAURA | Open-market sale | 25/05/16 | 25/05/20 | 1,519 sh | $5.15 | $7,822.85 | −2.6% |
David Michael JohnsonDirector | Aura BiosciencesAURA | Open-market buy | 25/05/16 | 25/05/20 | 20,000 sh | $4.90 | $98,000 | +13.7% |
Conor KilroySEE REMARKS | Aura BiosciencesAURA | Open-market sale | 25/04/16 | 25/04/16 | 7,162 sh | $5.49 | $39,319.38 | −3.8% |